Capricor Therapeutics CAPR
NASDAQ CAPR
$8.95 +0.01 (+0.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Capricor Therapeutics (CAPR) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Capricor Therapeutics' Return on Capital Employed [ROCE] was -42.97% in Q2 2026, up 20.71 percentage points from -63.68% a year earlier but down 3.96 percentage points from the prior quarter.

Analysis

Capricor Therapeutics (CAPR) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Capricor Therapeutics came in at -47.56%, down 2.08 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of +21.25 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -45.48% in FY2024 (+58.55 pp), -104.03% in FY2023 (+30.19 pp), -134.22% in FY2022 (-72.35 pp) and -61.87% in FY2021 (+6.94 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -356.58% (Q3 2023) and -38.45% (Q4 2024) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in six of the last eight quarters, with an average year-over-year change of +64.40 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2024 (a gain of 276.50 percentage points); the worst was Q3 2023 (a drop of 271.19 percentage points).
  • Per Business Quant data, CAPR's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -39.00% (Q1 2026), -52.66% (Q4 2025) and -85.10% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Capricor Therapeutics 519.49 Mn 519.49 Mn - -42.97%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -42.97%
Mar 31, 2026 -39.00%
Dec 31, 2025 -52.66%
Sep 30, 2025 -85.10%
Jun 30, 2025 -63.68%
Mar 31, 2025 -40.98%
Dec 31, 2024 -38.45%
Sep 30, 2024 -80.08%
Jun 30, 2024 -139.51%
Mar 31, 2024 -94.42%
Dec 31, 2023 -144.41%
Sep 30, 2023 -356.58%
Jun 30, 2023 -206.15%
Mar 31, 2023 -202.40%
Dec 31, 2022 -104.48%
Sep 30, 2022 -85.39%
Jun 30, 2022 -61.62%
Mar 31, 2022 -60.84%
Dec 31, 2021 -54.98%
Sep 30, 2021 -48.64%
API Access

Capricor Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CAPR&period=max&api_key=YOUR_API_KEY